Peter Ang

Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk et al. · Journal of Clinical Oncology · 2019 · 393 citations · Full text

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer

Henry Gómez, Dinesh Chandra Doval, Miguel A. Chavez et al. · Journal of Clinical Oncology · 2008 · 340 citations · Full text

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors

Wan‐Teck Lim, E.H. Tan, Chee‐Keong Toh et al. · Annals of Oncology · 2009 · 139 citations

Solid Tumors, Medicine, Pharmacology +5

Influence of <i>ABCB1</i> and <i>ABCG2</i> polymorphisms on doxorubicin disposition in Asian breast cancer patients

Suman Lal, Zee Wan Wong, Edwin Sandanaraj et al. · Cancer Science · 2008 · 133 citations · Full text

Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer

Swan Swan Leong, Eng Huat Tan, Kam Weng Fong et al. · Journal of Clinical Oncology · 2003 · 126 citations